Gain Therapeutics (GANX) Institutional Ownership $2.28 -0.09 (-3.80%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)CurrentInstitutional OwnershipPercentage11.97%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$737.67KNumber ofInstitutional Sellers(last 12 months)0 Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GANX Institutional Buying and Selling by Quarter Gain Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC271,972$484K0.0%+48.0%1.065% 8/9/2024Renaissance Technologies LLC118,700$152K0.0%+154.2%0.658% 8/9/2024Warberg Asset Management LLC51,600$66K0.0%N/A0.286% 8/3/2024Hohimer Wealth Management LLC330,000$422K0.1%N/A1.828% 1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184% 7/25/2023Raymond James & Associates33,400$150K0.0%+67.0%0.271% 5/8/2023CM Management LLC90,000$434K0.5%-18.2%0.740% 5/2/2023 Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105% 4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168% 2/9/2023CM Management LLC110,000$344K0.4%-12.0%0.926% Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/17/2023 Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158% 11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263% 10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202% 10/12/2022 Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210% 5/9/2022CM Management LLC125,000$511K0.4%+38.9%1.052% 2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085% 2/2/2022CM Management LLC90,000$489K0.4%+39.9%0.758% 11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810% 11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211% 11/9/2021Indie Asset Partners LLC29,652$221K0.2%N/A0.250% 11/8/2021CM Management LLC64,327$479K0.4%+543.3%0.542% 8/17/2021Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421% 8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255% 8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025% 8/10/2021CM Management LLC10,000$100K0.1%N/A0.084% 5/27/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/19/2021Worth Venture Partners LLC15,532$232K0.1%N/A0.131% 5/18/2021Millennium Management LLC14,367$214K0.0%N/A0.121% 5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602% 5/18/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/18/2021Jane Street Group LLC22,754$339K0.0%N/A0.192% (Data available from 1/1/2016 forward) GANX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GANX shares? During the previous two years, the following institutional investors and hedge funds held shares of Gain Therapeutics shares: Geode Capital Management LLC ($484K), CM Management LLC ($434K), Hohimer Wealth Management LLC ($422K), Renaissance Technologies LLC ($152K), Raymond James & Associates ($78K), and Warberg Asset Management LLC ($66K), and Wealth Alliance Advisory Group LLC ($60K).Learn more on GANX's institutional investors. What percentage of Gain Therapeutics stock is owned by institutional investors? 11.97% of Gain Therapeutics stock is owned by institutional investors. Learn more on GANX's institutional investor holdings. Which institutional investors have been buying Gain Therapeutics stock? The following institutional investors have purchased Gain Therapeutics stock in the last 24 months: Hohimer Wealth Management LLC ($330K), Geode Capital Management LLC ($88.24K), Renaissance Technologies LLC ($72K), Warberg Asset Management LLC ($51.60K), and Raymond James & Associates ($13.40K). How much institutional buying is happening at Gain Therapeutics? Institutional investors have bought a total of 555,236 shares in the last 24 months. This purchase volume represents approximately $797.70K in transactions. Which Gain Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Gain Therapeutics stock in the last 24 months: CM Management LLC ($35K), Raymond James & Associates ($14.01K), and Wealth Alliance Advisory Group LLC ($6.25K). How much institutional selling is happening at Gain Therapeutics? Institutional investors have sold a total of 55,261 shares in the last 24 months. This volume of shares sold represents approximately $225.44K in transactions. Related Companies COMPASS Pathways Major Shareholders Fulcrum Therapeutics Major Shareholders SOPHiA GENETICS Major Shareholders Larimar Therapeutics Major Shareholders Aurora Cannabis Major Shareholders 4D Molecular Therapeutics Major Shareholders Ocugen Major Shareholders Amylyx Pharmaceuticals Major Shareholders Acelyrin Major Shareholders DiaMedica Therapeutics Major Shareholders This page (NASDAQ:GANX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gain Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GANX Stock Alerts